FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 333:206-214 July 27, 1995 Number 4 Next

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background Preoperative transfusions are frequently given to prevent perioperative morbidity in patients with sickle cell anemia. There is no consensus, however, on the best regimen of transfusions for this purpose.

Methods We conducted a multicenter study to compare the rates of perioperative complications among patients randomly assigned to receive either an aggressive transfusion regimen designed to decrease the hemoglobin S level to less than 30 percent (group 1) or a conservative regimen designed to increase the hemoglobin level to 10 g per deciliter (group 2).

Results Patients undergoing a total of 604 operations were randomly assigned to group 1 or group 2. The severity of the disease, compliance with the protocol, and the types of operations were similar in the two groups. The preoperative hemoglobin level was 11 g per deciliter in group 1 and 10.6 g per deciliter in group 2. The preoperative value for hemoglobin S was 31 percent in group 1 and 59 percent in group 2. The most frequent operations were cholecystectomies (232), head and neck surgery (156), and orthopedic surgery (72). With the exception of transfusion-related complications, which occurred in 14 percent of the operations in group 1 and in 7 percent of those in group 2, the frequency of serious complications was similar in the two groups (31 percent in group 1 and 35 percent in group 2). The acute chest syndrome developed in 10 percent of both groups and resulted in two deaths in group 1. A history of pulmonary disease and a higher risk associated with surgery were significant predictors of the acute chest syndrome.

Conclusions A conservative transfusion regimen was as effective as an aggressive regimen in preventing perioperative complications in patients with sickle cell anemia, and the conservative approach resulted in only half as many transfusion-associated complications.

Source Information

From the Department of Hematology/Oncology, Children's Hospital Oakland, Oakland, Calif. (E.P.V., L.N., A.N.E.); the Departments of Anesthesia and Pediatrics, University of Washington and Children's Hospital and Medical Center, Seattle (C.M.H.); the Prevention Sciences Group, University of California, San Francisco (D.B.); the Department of Medicine, University of Illinois, Chicago (M.K.); the Department of Pediatrics, University of Miami, Miami (C.P.); the Department of Pediatrics, Medical University of South Carolina, Charleston (M.A.); the Department of Hematology, Children's Hospital, Philadelphia (K.O.-F.); and the Pediatric Hematology Department, University of Mississippi, Jackson (R.V.I.).

Address reprint requests to Dr. Vichinsky at the Department of Hematology/Oncology, Children's Hospital Oakland, 747 52nd St., Oakland, CA 94609.

Full Text of this Article

Related Letters:

Conservative versus Aggressive Transfusion Regimens in Sickle Cell Disease
Buchanan G. R., Rogers Z. R., Apfelroth S., Vichinsky E., Neumayr L., Black D.
Extract | Full Text  
N Engl J Med 1995; 333:1641-1642, Dec 14, 1995. Correspondence

This article has been cited by other articles:

• Firth, P. G., Gladwin, M. T., Kato, G. J., Vichinsky, E. (2009). Pulmonary Complications of Sickle Cell Disease. NEJM 360: 1044-1045 [Full Text]  
• Edwards, H. D., Sabio, H., Shihabi, Z. K. (2009). Rapid Quantitation of Hemoglobin S in Sickle Cell Patients Using the Variant II Turbo Analyzer. Annals of Clinical & Laboratory Science 39: 32-37 [Abstract] [Full Text]  
• Montalembert, M. d. (2008). Management of sickle cell disease. BMJ 337: a1397-a1397 [Full Text]  
• Dulvadestin, P., Gilton, A., Hernigou, P., Marty, J. (2008). The Onset Time of Atracurium Is Prolonged in Patients with Sickle Cell Disease. Anesth. Analg. 107: 113-116 [Abstract] [Full Text]  
• Higgins, J. M., Eddington, D. T., Bhatia, S. N., Mahadevan, L. (2007). Sickle cell vasoocclusion and rescue in a microfluidic device. Proc. Natl. Acad. Sci. USA 104: 20496-20500 [Abstract] [Full Text]  
• Egrie, G., Woodson, K., Alphonso, N., Karl, T. R. (2007). A Child With Sickle Cell Disease and Anomalous Right Coronary Artery. Ann. Thorac. Surg. 84: 2114-2116 [Abstract] [Full Text]  
• Buchanan, G. R., Kahn, M. J. (2007). Hemolytic anemias. ASH-SAP 2007: 102-142 [Full Text]  
• Neumayr, L. D., Aguilar, C., Earles, A. N., Jergesen, H. E., Haberkern, C. M., Kammen, B. F., Nancarrow, P. A., Padua, E., Milet, M., Stulberg, B. N., Williams, R. A., Orringer, E. P., Graber, N., Robertson, S. M., Vichinsky, E. P., the National Osteonecrosis Trial in Sickle Cell An, (2006). Physical Therapy Alone Compared with Core Decompression and Physical Therapy for Femoral Head Osteonecrosis in Sickle Cell Disease. Results of a Multicenter Study at a Mean of Three Years After Treatment. JBJS 88: 2573-2582 [Abstract] [Full Text]  
• Swerdlow, P. S. (2006). Red Cell Exchange in Sickle Cell Disease. ASH Education Book 2006: 48-53 [Abstract] [Full Text]  
• Tziomalos, K., Garipidou, V., Houmpouridou, E., Pitsis, A. A., Basayannis, E. (2005). Mitral valve reconstruction in a compound heterozygote for sickle cell anemia and hemoglobin Lepore. J. Thorac. Cardiovasc. Surg. 130: 932-933 [Full Text]  
• Firth, P. G. (2005). Anaesthesia for peculiar cells--a century of sickle cell disease. Br J Anaesth 95: 287-299 [Abstract] [Full Text]  
• Jeong, G. K., Ruchelsman, D. E., Jazrawi, L. M., Jaffe, W. L. (2005). Total Hip Arthroplasty in Sickle Cell Hemoglobinopathies. J Am Acad Orthop Surg 13: 208-217 [Abstract] [Full Text]  
• Lottenberg, R., Hassell, K. L. (2005). An Evidence-Based Approach to the Treatment of Adults with Sickle Cell Disease. ASH Education Book 2005: 58-65 [Abstract] [Full Text]  
• Sarjeant, J. M., Callum, J. L., Al-Ghamdi, A. A. (2004). The Use of Tourniquets in Patients with Sickle Cell Disease * Response. Anesth. Analg. 99: 630-630 [Full Text]  
• Tobin, J. R., Butterworth, J. (2004). Sickle Cell Disease: Dogma, Science, and Clinical Care. Anesth. Analg. 98: 283-284 [Full Text]  
• Wilson, R. E., Krishnamurti, L., Kamat, D. (2003). Management of Sickle Cell Disease in Primary Care. CLIN PEDIATR 42: 753-761  
• Miller, S. T., Rao, S. P., Boyd, J. H., DeBaun, M. R. (2003). Acute chest syndrome, transfusion, and neurologic events in children with sickle cell disease. Blood 102: 1556-1557 [Full Text]  
• Section on Hematology/Oncology and Committee on Ge, (2002). Health Supervision for Children with Sickle Cell Disease. Pediatrics 109: 526-535 [Abstract] [Full Text]  
• Walters, M. C., Nienhuis, A. W., Vichinsky, E. (2002). Novel Therapeutic Approaches in Sickle Cell Disease. ASH Education Book 2002: 10-34 [Abstract] [Full Text]  
• (2001). Acute complications of sickle cell disease in children. DTB 39: 33-37 [Abstract] [Full Text]  
• Vichinsky, E. P., Neumayr, L. D., Earles, A. N., Williams, R., Lennette, E. T., Dean, D., Nickerson, B., Orringer, E., McKie, V., Bellevue, R., Daeschner, C., Manci, E. A., Abboud, M., Moncino, M., Ballas, S., Ware, R., The National Acute Chest Syndrome Study Group, (2000). Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease. NEJM 342: 1855-1865 [Abstract] [Full Text]  
• Djaiani, G. N., Cheng, D. C. H., Carroll, J. A., Yudin, M., Karski, J. M. (1999). Fast-Track Cardiac Anesthesia in Patients with Sickle Cell Abnormalities. Anesth. Analg. 89: 598-598 [Abstract] [Full Text]  
• Steinberg, M. H. (1999). Management of Sickle Cell Disease. NEJM 340: 1021-1030 [Full Text]  
• Hebert, P. C., Wells, G., Blajchman, M. A., Marshall, J., Martin, C., Pagliarello, G., Tweeddale, M., Schweitzer, I., Yetisir, E., The Transfusion Requirements in Critical Care Inve, (1999). A Multicenter, Randomized, Controlled Clinical Trial of Transfusion Requirements in Critical Care. NEJM 340: 409-417 [Abstract] [Full Text]  
• Cohen, A. R. (1998). Sickle Cell Disease -- New Treatments, New Questions. NEJM 339: 42-44 [Full Text]  
• Halvorson, D. J., McKie, V., McKie, K., Ashmore, P. E., Porubsky, E. S. (1997). Sickle Cell Disease and Tonsillectomy: Preoperative Management and Postoperative Complications. Arch Otolaryngol Head Neck Surg 123: 689-692 [Abstract]  
• YUNG, G. L., CHANNICK, R. N., FEDULLO, P. F., AUGER, W. R., KERR, K. M., JAMIESON, S. W., KAPELANSKI, D. P., MOSER, K. M. (1997). Successful Pulmonary Thromboendarterectomy in Two Patients with Sickle Cell Disease. Am. J. Respir. Crit. Care Med. 157: 1690-1693 [Abstract] [Full Text]  
• Haberkern, C. M., Neumayr, L. D., Orringer, E. P., Earles, A. N., Robertson, S. M., Black, D., Abboud, M. R., Koshy, M., Idowu, O., Vichinsky, E. P., the Preoperative Transfusion in Sickle Cell Diseas, (1997). Cholecystectomy in Sickle Cell Anemia Patients: Perioperative Outcome of 364 Cases From the National Preoperative Transfusion Study. Blood 89: 1533-1542 [Abstract] [Full Text]  
• Vichinsky, E. P., Styles, L. A., Colangelo, L. H., Wright, E. C., Castro, O., Nickerson, B., the Cooperative Study of Sickle Cell Disease, (1997). Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Course. Blood 89: 1787-1792 [Abstract] [Full Text]  
• Buchanan, G. R., Rogers, Z. R., Apfelroth, S., Vichinsky, E., Neumayr, L., Black, D. (1995). Conservative versus Aggressive Transfusion Regimens in Sickle Cell Disease. NEJM 333: 1641-1642 [Full Text]  
• (1995). PREOPERATIVE TRANSFUSION REGIMENS FOR SICKLE-CELL PATIENTS COMPARED. JWatch General 1995: 5-5 [Full Text]